Revolutionary Bio-ink for Bone Repair Patented by NITR
Researchers at the National Institute of Technology, Rourkela (NITR), recently developed a groundbreaking 3D Bioprinting Bio-ink. This innovation effectively addresses the common limitations of current materials in tissue engineering. Specifically, it bridges the gap between biological performance and mechanical strength for clinical applications.
Advanced Features of the 3D Bioprinting Bio-ink
The research team combined bovine serum albumin (BSA) and sodium alginate to create this composite. Furthermore, they integrated polyelectrolyte complexes of gelatin and chitosan (PEC-GC). This unique blend ensures that the material maintains high shape fidelity during the printing process. Consequently, the printed structures support cell growth effectively without collapsing.
Associate Professor Devendra Verma led the project along with scholars Shreya Chrungoo and Tanmay Bharadwaj. Their research findings appeared in the International Journal of Biological Macromolecules. Additionally, the Indian government granted patent number 583759 for this technology on March 18, 2026. Therefore, this development marks a significant milestone in Indian regenerative medicine.
Laboratory Success and Future Medical Use
Extensive lab trials confirmed that the ink mimics the bone tissue’s extracellular matrix. For instance, scaffolds containing 2% PEC-GC achieved over 90% cell viability in experiments. Moreover, the material actively promotes collagen synthesis and natural bone formation. These properties make it ideal for creating patient-specific implants with precise geometry.
The team now prepares for animal studies to further establish safety and efficacy. Subsequently, they will initiate clinical trials to validate these findings in human patients. This innovation offers new hope for personalized healthcare solutions. Finally, it may transform how surgeons approach complex cartilage and bone repair in the near future.
Frequently Asked Questions
Q1: What materials are used in the NIT Rourkela 3D Bioprinting Bio-ink?
The bio-ink is a composite of bovine serum albumin (BSA), sodium alginate, and polyelectrolyte complexes of gelatin and chitosan (PEC-GC).
Q2: How does this new bio-ink improve upon existing options?
It provides high shape fidelity and mechanical strength while maintaining over 90% cell viability. Most existing bio-inks struggle to balance these three critical factors.
Q3: What are the primary medical applications for this technology?
The technology is specifically designed for bone and cartilage repair. It allows for the fabrication of custom, tissue-like structures for regenerative medicine.
References
- NITR team develops bio-ink to aid 3D bioprinting, tissue engineering – ETHealthworld
- NIT Rourkela patents bio-ink for 3D-printed tissue repair – OrissaPOST
- NIT Rourkela develops patented bio-ink for bone, cartilage repair – Business Standard
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.
